During our analysis, we observed significant differences in clinical characteristics such as gender, smoking history, type of nodules, tumor long axis, and tumor short axis between patients with EGFR mutations and those with wild-type EGFR (with p < 0.05 in both the training and test sets). This evidence concerns the gene EGFR and neoplasm.